Design of α-helical antimicrobial peptides with a high selectivity index
Authors/Creators
Description
Introduction: Low-molecular-weight antibiotics are gradually rendered ineffective by multidrug-resistant bacteria. Promising replacements are fast-acting antimicrobial peptides, either naturally occurring as host defense peptides or designed; however, their main weakness in applications is their low selectivity for bacterial cells.
Areas covered: This paper examines the extent to which human design has enhanced the evolutionary design of linear alpha-class antimicrobial peptides with selective antibacterial activity. Activity data against E. coli and S. aureus are collected from numerous publications reporting the hemolytic activity as well. Overall performance parameters are defined to facilitate the easier ranking of the best-performing peptides.
Expert opinion: Connecting structure to the specific activity of antimicrobial peptides should include considerations of which peptide features channel adaptable conformational changes toward pore-inducing interactions with anionic membranes. Imperfect amphipathicity, enhanced flexibility, self-assembly potential, and an oblique, only partially helical structure, can improve structure-activity and structure-selectivity relationships. The number of optimal combinations of antimicrobial activity and low toxicity is immense when dedicated databases are constructed, the best descriptors extracted and followed through model building, simulations, and selectivity predictions, with everything tightly connected to feedback cycles of in vitro testing.
Article highlights
Natural and designed antimicrobial peptides are ranked according to their selectivity index and overall performance against standard E. coli and S. aureus strains.
The helix-hinge-helix structure is a frequent feature in longer peptides with promising antibacterial selectivity, which can span the membrane.
The sequence profile of hydrophobic moments can often be used as a quick indication that a peptide may form such a structure at the membrane surface.
For shorter peptides, the human-designed sequences produced a greater number of lead sequences superior to natural ones in antibacterial activity and selectivity.
A design driven by simulations of dipole moments, quadrupole moments, and 3D moments during dynamic peptide-lipid interactions can help in getting promising leads for human needs.
Currently underexplored is the design of conformationally flexible peptides that induce changes in bilayer structure by self-association and interaction with specific polar lipids from anionic membranes.
Davor Juretić notes in 2025: It is a special pleasure to design, test, and name promising candidates for novel antibiotics. Thus, I am a proud father of adepantins (A1), apepantin-1-analogue (A1A), diPGLa-H (PG2), kiadins, [I2, K19]-ascaphin-8, [K2, K16]-XT-7, trichoplaxin (T1), trichoplaxin-2-analogue (T2A), mapegin (MAPA), ZYK-1 (ZYK), and flexampin (FLEX). All peptides are C-terminally amidated. Their primary structures are:
A1 = GIGKHVGKALKGLKGLLKGLGES
A1A = GIKKAVGKALKGLKGLLKALGES
PG2 = KIAKVALKALKIAKVALKAL
T1 = FFGRLKSVWSAVKHGWKAAKSR
T2A = RHHWRRYARIGFRAVRTVIGK
MAPA = KIGKKILKALKGALKELA
ZYK = GIGREIIKKIIKKIGKKIGRII
FLEX = GIKKWVKGVAKGVAKDLAKKIL
Files
Files
(14.9 kB)
| Name | Size | |
|---|---|---|
|
md5:2d9dce24be01bf65b45c06ba04d54bc4
|
14.9 kB | Download |